Dosage and administration
Apply evenly to face prior to sun exposure.
Apply evenly to face prior to sun exposure.
Apply evenly to face prior to sun exposure.
7.0% Octinoxate (2-Ethylhexyl Methoxycinnamate), 2.9% Zinc Oxide.
Water (Aqua) (Eau), Phenyl Trimethicone, Hydrogenated Polyisobutene, Butylene Glycol, C12-15 Alkyl Benzoate, Potassium Cetyl Phosphate, Acrylates Copolymer, Caprylyl Glycol, Hydroxyethyl Acrylate/ Sodium Acryloyldimethyltaurate Copolymer, Polysorbate 60, Squalane, Honey (Mel) (Miel), Pectin, Lecithin, C20-22 Alcohols, C20-22 Alkyl Phosphate, Glyceryl Stearate, PEG 100 Stearate, Polysilicone-11, Phenoxyethanol, Dimethicone, Oligopeptide-10, Silica, Betaine, Hydrogenated Lecithin, Tetrahexyldecyl Ascorbate, Ethoxydiglycol, Xanthan Gum, Polyhydroxystearic Acid, Propylene Glycol Stearate, Triethanolamine, Triethoxy Caprylylsilane, Polysorbate 20, Sorbitan Laurate, Tocopheryl Acetate, Glycerin, Propylene Glycol Laurate, Sodium Dehydroacetate, Tetrasodium EDTA. May Contain/Peut Contenir: Titanium Dioxide (CI 77891), Iron Oxides (CI 77491, CI 77492, CI 77499).
For external use only.
When using this product: Keep out of eyes. Rinse with water to remove.
Stop use and ask a doctor if: rash or irritation develops and lasts.
Keep out of reach of children. Children under six months of age: ask doctor.
Sun alert: The sun may cause sunburn, premature ageing of skin and skin cancer. Avoiding the sun, wearing protective clothing and regular use of sunscreens over the years may reduce the chance of these harmful effects.
Dist. Smashbox Beauty Cosmetics, Inc.
Culver City, CA 90232
Northampton, NN1 2QZ,United Kingdom
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| d1c9d1af-bddd-448d-86f7-69052b7d5b47 | Product name | 1 | 20220627 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 10348-003-01 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-97d8-f424-e053-dadaa90a57ce | SHEER FOCUS TINTED MOISTURIZER |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 10348-003-01 | SHEER FOCUS TINTED MOISTURIZER | 1 in 1 CARTON | LIQUID | 1 | 1 | |
| 10348-003-01 | SHEER FOCUS TINTED MOISTURIZER | 50 mL in 1 TUBE | LIQUID | 50 | 1 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| OCTINOXATE | ACTIVE INGREDIENT | 4Y5P7MUD51 | 1 | |
| ZINC OXIDE | ACTIVE INGREDIENT | SOI2LOH54Z | 1 | |
| OCTINOXATE | ACTIVE MOIETY | 4Y5P7MUD51 | 1 | |
| ZINC OXIDE | ACTIVE MOIETY | SOI2LOH54Z | 1 | |
| Alkyl (C12-15) Benzoate | INACTIVE INGREDIENT | A9EJ3J61HQ | 1 | |
| Alpha-Tocopherol Acetate | INACTIVE INGREDIENT | 9E8X80D2L0 | 1 | |
| Betaine | INACTIVE INGREDIENT | 3SCV180C9W | 1 | |
| Butylene Glycol | INACTIVE INGREDIENT | 3XUS85K0RA | 1 | |
| C20-22 Alcohols | INACTIVE INGREDIENT | O4M0347C6A | 1 | |
| C20-22 Alkyl Phosphate | INACTIVE INGREDIENT | L4VKP0Y7RP | 1 | |
| Caprylyl Glycol | INACTIVE INGREDIENT | 00YIU5438U | 1 | |
| Diethylene Glycol Monoethyl Ether | INACTIVE INGREDIENT | A1A1I8X02B | 1 | |
| Dimethicone | INACTIVE INGREDIENT | 92RU3N3Y1O | 1 | |
| Edetate Sodium | INACTIVE INGREDIENT | MP1J8420LU | 1 | |
| Ferric Oxide Red | INACTIVE INGREDIENT | 1K09F3G675 | 1 | |
| Ferric Oxide Yellow | INACTIVE INGREDIENT | EX438O2MRT | 1 | |
| Ferrosoferric Oxide | INACTIVE INGREDIENT | XM0M87F357 | 1 | |
| Glycerin | INACTIVE INGREDIENT | PDC6A3C0OX | 1 | |
| Glyceryl Monostearate | INACTIVE INGREDIENT | 230OU9XXE4 | 1 | |
| Honey | INACTIVE INGREDIENT | Y9H1V576FH | 1 | |
| Hydrogenated Soybean Lecithin | INACTIVE INGREDIENT | H1109Z9J4N | 1 | |
| Pectin | INACTIVE INGREDIENT | 89NA02M4RX | 1 | |
| Peg-100 Stearate | INACTIVE INGREDIENT | YD01N1999R | 1 | |
| Phenoxyethanol | INACTIVE INGREDIENT | HIE492ZZ3T | 1 | |
| Phenyl Trimethicone | INACTIVE INGREDIENT | DR0K5NOJ4R | 1 | |
| Polysorbate 20 | INACTIVE INGREDIENT | 7T1F30V5YH | 1 | |
| Polysorbate 60 | INACTIVE INGREDIENT | CAL22UVI4M | 1 | |
| Potassium Cetyl Phosphate | INACTIVE INGREDIENT | 03KCY6P7UT | 1 | |
| Silicon Dioxide | INACTIVE INGREDIENT | ETJ7Z6XBU4 | 1 | |
| Sodium Dehydroacetate | INACTIVE INGREDIENT | 8W46YN971G | 1 | |
| Sorbitan Monolaurate | INACTIVE INGREDIENT | 6W9PS8B71J | 1 | |
| Squalane | INACTIVE INGREDIENT | GW89575KF9 | 1 | |
| Tetrahexyldecyl Ascorbate | INACTIVE INGREDIENT | 9LBV3F07AZ | 1 | |
| Titanium Dioxide | INACTIVE INGREDIENT | 15FIX9V2JP | 1 | |
| Triethoxycaprylylsilane | INACTIVE INGREDIENT | LDC331P08E | 1 | |
| Trolamine | INACTIVE INGREDIENT | 9O3K93S3TK | 1 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | 1 | |
| Xanthan Gum | INACTIVE INGREDIENT | TTV12P4NEE | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 10348-003 | 10348-003-01 |
Every source-derived ingredient row is available through these pages.
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Sorbitan Monolaurate | SORBITAN MONOLAURATE | 6W9PS8B71J | CAPSULE / ORAL | 0.08 mg | ||
| Edetate Sodium | EDETATE SODIUM | MP1J8420LU | SOLUTION / TOPICAL | 0.3 %w/w | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION / TOPICAL | 1971 mg | ||
| Ferric Oxide Yellow | FERRIC OXIDE YELLOW | EX438O2MRT | POWDER / RESPIRATORY (INHALATION) | 0.04 mg | ||
| Polysorbate 20 | POLYSORBATE 20 | 7T1F30V5YH | SUSPENSION / OPHTHALMIC | 0.05 %w/v | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | GEL / DENTAL | 19 %w/w | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | INJECTION, SOLUTION / SUBCUTANEOUS | 15 %w/v | ||
| Polysorbate 20 | POLYSORBATE 20 | 7T1F30V5YH | INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS | NA | ||
| Polysorbate 60 | POLYSORBATE 60 | CAL22UVI4M | SUPPOSITORY / VAGINAL | 0.03 mg | ||
| Sorbitan Monolaurate | SORBITAN MONOLAURATE | 6W9PS8B71J | AEROSOL, FOAM / TOPICAL | 341 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | PELLET / ORAL | 34 mg | ||
| Ferric Oxide Red | FERRIC OXIDE RED | 1K09F3G675 | CAPSULE, DELAYED RELEASE / ORAL | 14 mg | ||
| Xanthan Gum | XANTHAN GUM | TTV12P4NEE | FILM, SOLUBLE / ORAL | 1 mg | ||
| Phenoxyethanol | PHENOXYETHANOL | HIE492ZZ3T | CREAM, AUGMENTED / TOPICAL | 10 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SPRAY, METERED / NASAL | 13 mg | ||
| Sorbitan Monolaurate | SORBITAN MONOLAURATE | 6W9PS8B71J | CREAM / TOPICAL | 0.5 %w/w | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | DOUCHE / VAGINAL | 1 %w/w | ||
| Edetate Sodium | EDETATE SODIUM | MP1J8420LU | SOAP / TOPICAL | 0.12 %w/w | ||
| Titanium Dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | SUPPOSITORY, EXTENDED RELEASE / INTRAUTERINE | 1 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | TABLET / ORAL | 42 mg | ||
| Xanthan Gum | XANTHAN GUM | TTV12P4NEE | SOLUTION, GEL FORMING, EXTENDED RELEASE / OPHTHALMIC | 0.6 %w/w | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | JELLY / VAGINAL | NA | ||
| Squalane | SQUALANE | GW89575KF9 | POWDER / ORAL | 0.02 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE / RESPIRATORY (INHALATION) | NA | ||
| Polysorbate 60 | POLYSORBATE 60 | CAL22UVI4M | AEROSOL, FOAM / TOPICAL | 30 mg | ||
| Titanium Dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | SHAMPOO, SUSPENSION / TOPICAL | 3 %w/v | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | TABLET / PERIODONTAL | 0.53 mg | ||
| Titanium Dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | 42 mg | ||
| Titanium Dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET, FILM COATED / ORAL | 36 mg | ||
| Polysorbate 60 | POLYSORBATE 60 | CAL22UVI4M | GUM, CHEWING / BUCCAL | 5 mg | ||
| Hydrogenated Soybean Lecithin | HYDROGENATED SOYBEAN LECITHIN | H1109Z9J4N | TABLET / ORAL | 0.21 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, FOR SUSPENSION / ORAL | 220 mg | ||
| Trolamine | TROLAMINE | 9O3K93S3TK | SPONGE / TOPICAL | 11 %w/w | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | LOZENGE / ORAL | 120 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | INJECTION, SUSPENSION / SUBCUTANEOUS | 1.6 %w/v | ||
| Ferric Oxide Yellow | FERRIC OXIDE YELLOW | EX438O2MRT | TABLET / ORAL | 24 mg | ||
| Xanthan Gum | XANTHAN GUM | TTV12P4NEE | SUSPENSION/ DROPS / ORAL | 22 mg | ||
| Xanthan Gum | XANTHAN GUM | TTV12P4NEE | TABLET / ORAL | 56 mg | ||
| Xanthan Gum | XANTHAN GUM | TTV12P4NEE | PASTE / ORAL | 1050 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | FILM, EXTENDED RELEASE / TRANSDERMAL | 306.2 mg | ||
| Xanthan Gum | XANTHAN GUM | TTV12P4NEE | TABLET, EXTENDED RELEASE / ORAL | 528 mg | ||
| Glyceryl Monostearate | GLYCERYL MONOSTEARATE | 230OU9XXE4 | SUSPENSION / OPHTHALMIC | 0.5 %w/v | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SOAP / TOPICAL | 0.76 %w/w | ||
| Edetate Sodium | EDETATE SODIUM | MP1J8420LU | SPONGE / TOPICAL | 0.14 %w/w | ||
| Edetate Sodium | EDETATE SODIUM | MP1J8420LU | INJECTION / INTRAMUSCULAR | 0.01 %w/v | ||
| Titanium Dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | CAPSULE / ORAL | 72 mg | ||
| Titanium Dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | DROPS / ORAL | NA | ||
| Xanthan Gum | XANTHAN GUM | TTV12P4NEE | SOLUTION / ORAL | 84 mg | ||
| Trolamine | TROLAMINE | 9O3K93S3TK | INJECTION, POWDER, FOR SUSPENSION / INTRAVENOUS | 0.02 %w/v | ||
| Polysorbate 20 | POLYSORBATE 20 | 7T1F30V5YH | TABLET / ORAL | 17 mg | ||
| Titanium Dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | CAPSULE, LIQUID FILLED / ORAL | 12 mg | ||
| Glyceryl Monostearate | GLYCERYL MONOSTEARATE | 230OU9XXE4 | LIQUID / TOPICAL | 1 %w/w | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE, EXTENDED RELEASE / ORAL | 168 mg | ||
| Polysorbate 20 | POLYSORBATE 20 | 7T1F30V5YH | CREAM / TOPICAL | 108 mg | ||
| Xanthan Gum | XANTHAN GUM | TTV12P4NEE | POWDER, FOR SOLUTION / ORAL | 10 mg/5ml | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | ELIXIR / ORAL | 5621 mg | ||
| Glyceryl Monostearate | GLYCERYL MONOSTEARATE | 230OU9XXE4 | EMULSION / ORAL | NA | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | PASTE / DENTAL | 34 %w/w | ||
| Ferrosoferric Oxide | FERROSOFERRIC OXIDE | XM0M87F357 | TABLET / ORAL | 2 mg | ||
| Titanium Dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | SYSTEM / TOPICAL | 420 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 886d9244-2d86-4538-9d4a-e799f7e19dc4 | 7038eba3-a583-498c-9b25-095864343aa7 | 2012-01-13 | Warnings | 886d9244-2d86-4538-9d4a-e799f7e19dc4 7038eba3-a583-498c-9b25-095864343aa7 |
Adverse event summaries are temporarily unavailable. Other product information remains available.